ERCC1 Antikörper

Produktnummer ABIN2720418

Der Maus Monoklonal Anti-ERCC1-Antikörper wurde für WB, IF, ICC und IHC (p) validiert. Er ist geeignet, ERCC1 in Proben von Human zu detektieren. Es sind 8+ Publikationen verfügbar.

Kurzübersicht für ERCC1 Antikörper (ABIN2720418)

Target: ERCC1 (Excision Repair Cross Complementing Polypeptide-1 (ERCC1))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser ERCC1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon: 4F9

Produktdetails anti-ERCC1 Antikörper

Aufreinigung: Purified from mouse ascites fluids by affinity chromatography

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Referenzen für anti-ERCC1 Antikörper (ABIN2720418)

Laufs, Altieri, Sbiera, Kircher, Steinhauer, Beuschlein, Quinkler, Willenberg, Rosenwald, Fassnacht, Ronchi: "ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas." in: European journal of endocrinology, Vol. 178, Issue 2, pp. 181-188, (2018) (PubMed).

Kuo, Adam, Dorvault, Robin, Friboulet, Soria, Olaussen: "A novel antibody-based approach to detect the functional ERCC1-202 isoform." in: DNA repair, Vol. 64, pp. 34-44, (2018) (PubMed).

Bahamon, Gao, Danaee: "Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors." in: Archives of pathology & laboratory medicine, Vol. 140, Issue 12, pp. 1397-1403, (2016) (PubMed).

Xiu, Jiang, Liu: "Classic biphasic pulmonary blastoma with brain and axillary metastases: a case report with molecular analysis and review of literature." in: International journal of clinical and experimental pathology, Vol. 8, Issue 1, pp. 983-8, (2015) (PubMed).

Puccetti, Fallarino, Italiano, Soubeyran, MacGrogan, Debled, Velasco, Bodet, Eimer, Veldhoen, Prendergast, Platten, Bessede, Guillemin: "Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers." in: PLoS ONE, Vol. 10, Issue 4, pp. e0122046, (2015) (PubMed).

Smith, Fiehn, Fogh, Christensen, Hansen, Stenvang, Nielsen, Nielsen, Hasselby, Brünner, Jensen: "Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody." in: Scientific reports, Vol. 4, pp. 4313, (2014) (PubMed).

Bauman, Austin, Schmidt, Kurland, Vaezi, Hayes, Mendez, Parvathaneni, Chai, Sampath, Martins: "ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial." in: British journal of cancer, Vol. 109, Issue 8, pp. 2096-105, (2013) (PubMed).

Ma, Baruch, Shu, Yuan, Sun, Ma, Hoang, Fu, Min, Lan, Wang, Mull, He: "Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology." in: BMC biotechnology, Vol. 12, pp. 88, (2012) (PubMed).

Details zu ERCC1

Target: ERCC1 (Excision Repair Cross Complementing Polypeptide-1 (ERCC1))

Andere Bezeichnung: Ercc1

Pathways: DNA Reparatur, Production of Molecular Mediator of Immune Response